Treatments · Entity Annotation Prototype (beta)

7articles mentioning treatments

9treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: placebo ×

placebo

This treatment is selected. Its supporting articles are shown below.

placebo7

Articles mentioning placebo

7 articles · page 1 of 1

156 Reducing over-diagnosis and over-treatment by creating continuous functions that estimate the probability of an outcome conditional on each possible test result that represents an individual patient’s disease severity for shared decision making

ebmed · abstract · 2026-02-09 · 2 matching annotations

76.0%

placebo veloped nephropathy irbesartan Type 2 diabetes mellitus irbesartan 300mg daily

…/68 developed nephropathy. Therefore, in the 39% of patients on placebo in this range, there is little prospect of developing nephropat…

Incidence of fractures in patients with solid cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis of randomised controlled trials

bmjonc · abstract · 2025-11-24 · 2 matching annotations

76.7%

chemotherapy placebo solid tumours ICIs PROSPERO cancer Embase PubMed PROSPERO

…solid cancer treated with ICIs compared with those treated with chemotherapy, placebo or no treatment. Risk of bias was evaluated with the C…

Reducing severe breathlessness with dronabinol in the group of patients with severe and very severe chronic obstructive pulmonary disease (BONG): a randomised, double-blinded, placebo-controlled, crossover study in an outpatient clinic in Denmark – a study protocol

bmjopen · abstract · 2026-02-16 · 1 matching annotations

77.0%

placebo dronabinol Numeric Rating Scale sCOPD European Union Clinical Trials Registry chronic obstructive pulmonary disease ClinicalTrials.gov Danish Medicines Agency

…evere chronic obstructive pulmonary disease (sCOPD) compared to placebo.Methods This single-centre, randomised, double-blinded, placebo…

Melatonin and melatonin agonists as antidepressants in the elderly: protocol for a systematic review and meta-analysis of randomised control trials

bmjopen · abstract · 2025-11-04 · 1 matching annotations

76.7%

placebo depression insomnia melatonin PROSPERO Cochrane Library SciELO PROSPERO

…onists in the treatment of depression. Comparators will include placebo and active treatments (eg, antidepressants). We will search int…

P89 A ‘call to action’ in determining and estimating a minimum important difference (MID) in 6-minute walking distance (6MWD) in PH-ILD

thoraxjnl · abstract · 2025-11-02 · 1 matching annotations

75.7%

TRT placebo Treprostinil pulmonary hypertension interstitial lung disease PH-ILD INCREASE NCT02630316 6MWD

…both a treatment (Treprostinil, TRT) and placebo (PLB) arm. The TRT arm was selected for the MID using the SRM, 0.5SD change with a…

Antipsychotics for Parkinson’s disease: a protocol for a systematic review with network meta-analysis and trial sequential analysis

bmjopen · abstract · 2025-09-26 · 1 matching annotations

80.8%

placebo Parkinson’s disease antipsychotics CENTRAL EMBASE PROSPERO

…omised clinical trials comparing antipsychotics to any control (placebo, standard care or other antipsychotics) in patients with Parkin…

Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis

bmj · abstract · 2025-09-02 · 1 matching annotations

75.3%

placebo osimertinib lazertinib gefitinib Almonertinib erlotinib NSCLC Embase Web of Science

…g 29 813 participants, mean follow-up 2.18 years. Compared with placebo, both first generation (odds ratio 1.51, 95% confidence interva…